Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Boolean logic in synthetic biology and biomaterials: Towards living materials in mammalian cell therapeutics

Clinical and Translational Medicine(2023)10.1002/ctm2.1244Source: DataRank Database

Boolean logic in synthetic biology and biomaterials: Towards living materials in mammalian cell therapeutics is a research paper published in Clinical and Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 41 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)OA: goldTopics (29)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Sarah Adams ORCID,Rong Liu ORCID,Yolonda L. Colson ORCID,Wilson W. Wong ORCID,Mark W. Grinstaff ORCID

Live enrichment

PubMed:37386762 PMC:PMC10310979

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01DK132576

National Institute of Biomedical Imaging and Bioengineering

Grant: R01EB017722

National Institute of Biomedical Imaging and Bioengineering

Grant: R01EB029483

National Institute of Biomedical Imaging and Bioengineering

Grant: R01EB031904

National Cancer Institute

Grant: U01CA265713

National Cancer Institute

Grant: R01CA232708

National Cancer Institute

Grant: F30CA257566

National Institute of General Medical Sciences

Grant: T32GM130546

NIBIB NIH HHS

Grant: T32 EB006359

National Institutes of Health

Grant: 5U01CA265713-03

Precise tumor targeting with logic CAR circuits

National Institutes of Health

Grant: 5R01EB029483-03

Synthetic toolkit for precision gene expression control and signal processing in mammalian cells

National Institutes of Health

Grant: 5F30CA257566-02

Development of a Surgical Drug Delivery System for Enhancement of CAR T Cell Activity

National Institutes of Health

Grant: 5T32GM130546-04

Synthetic Biology and Biotechnology (SB2) Predoctoral Training Program

National Institutes of Health

Grant: 5R01EB031904-02

Multiplexed and Logical Control of the Mammalian Transcriptome Using Cas13

National Institutes of Health

Grant: 1R01EB017722-01A1

Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma

National Institutes of Health

Grant: 5R01CA232708-05

SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCE

National Institutes of Health

Grant: 5R01DK132576-04

Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands

National Institutes of Health

NIH HHS

goldLicense: cc-by

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctm2.1244

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1244

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10310979/pdf/CTM2-13-e1244.pdf

repositoryhttps://doaj.org/article/5c2b8382c06044b387cb31a8b4f5bee6

Europe_PMChttps://europepmc.org/articles/PMC10310979

Fields of Study

AnimalsSynthetic BiologyBiocompatible MaterialsCell- and Tissue-Based TherapyDrug Delivery SystemsImmunotherapy, AdoptiveMammals

MeSH Terms

AnimalsMammalsBiocompatible MaterialsImmunotherapy, AdoptiveDrug Delivery SystemsSynthetic BiologyCell- and Tissue-Based Therapy

Keywords

Cell therapyBiomaterialsDrug DeliverySynthetic BiologyBoolean LogicCar T CellsMammalsMedicine (General)Cell- and Tissue-Based TherapyReviewsBiocompatible MaterialsImmunotherapy, AdoptiveR5-920Drug Delivery SystemsAnimals